Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areas
RSS SUMMARY · AGGREGATED FROM CNBC
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
Business
CBS fires veteran correspondent Scott Pelley amid turmoil over direction of ’60 Minutes’
CNBC·37m ago·3 min read
Business
Sellers are pulling homes off the market at the fastest pace since 2020
CNBC·54m ago·3 min read
US
Meta is trying to sell AI agents to businesses in latest effort to diversify away from ads
CNBC·1h ago·3 min read
Business
Morgan Stanley will soon open its trillion-dollar wealth management funnel to AI agents
CNBC·2h ago·3 min read
Related
On this beat
Business
Google parent Alphabet upsizes record-breaking equity raise to $85bn
FT·1h ago·3 min read
Business
Bari Weiss Speaks on Scott Pelley’s ’60 Minutes’ Firing: ‘That’s the Path That He Chose’
TNYT·53m ago·3 min read
Business
Costco adds an exclusive Coca-Cola soda rival
THE STREET·50m ago·3 min read
Business
Opinion | The Market Has Spoken: E15 Is a Net Positive
TWSJ·49m ago·3 min read